Meloxicam Market Trends

  • Report ID: 5360
  • Published Date: Nov 02, 2023
  • Report Format: PDF, PPT

Meloxicam Market Trends

Growth Drivers

  • Increasing Technological Advancement – The growth of this meloxicam market can be ascribed to an increasing technological advancement taking place in meloxicam. The global growth rate of the meloxicam retail market has been accelerated by the launch of new and enhanced goods as a result of the development of fresh technologies. Furthermore, advancements in drug delivery technologies and formulations are enhancing the efficacy and safety of meloxicam making it a more appealing treatment option.
  • Increasing Prevalence of NSAIDs - Increased preference for NSAIDs over other painkillers like opioids also contributes to the meloxicam market's expansion in the anticipated time period. NSAIDs such as meloxicam are at times preferred over other painkillers such as opioids owing to their lower risk of addiction and side effects. In addition, the meloxicam market is growing as chronic inflammation and pain illnesses become more prevalent.
  • Growing Strategic Collaboration and Partnerships – Pharmaceutical companies are collaborating with research institutions and other companies to develop new formulations and applications for meloxicam. Therefore, this is accelerating the market expansion of meloxicam in the upcoming time period. 

Challenges

  • Competition from other NSAIDs – Meloxicam is one of many NSAIDs on the market, and it faces stiff competition from other drugs in its class, such as ibuprofen and naproxen. These drugs are often less expensive than meloxicam and may have a better safety profile. Therefore, high competition by other NSAIDs is expected to hamper the meloxicam market growth of meloxicam in the forthcoming years.
  • Concerns Associated with Side Effects of Meloxicam is Predicted to Restrict the Market Expansion in the Future Times
  • The Availability of Generic Meloxicam is Posing a Limitation on the Market Expansion in Forecast Period.

Meloxicam Market: Key Insights

Base Year

2023

Forecast Year

2024 - 2036

CAGR

~5%

Base Year Market Size

~USD 7 billion

Forecast Year Market Size

~USD 47 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5360
  • Published Date: Nov 02, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The growing prevalence of chronic pain disease and increasing research and development in meloxicam are some of the major factors anticipated to drive the growth of the meloxicam market.

The market is anticipated to attain a CAGR of ~5% over the forecast period, i.e., 2024-2036.

The major players in the market are of Healthy Life Pharma Private Limited., EPICON LIFESCIENCES LLP, Boehringer Ingelheim GmbH., Baudax Bio, Heron Therapeutics Inc., Avanstra Inc., PD-Rx Pharmaceuticals, Inc., and others.

The osteoarthritis segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in North America is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying